AngioDynamics, Inc.
ANGO
$10.86
$1.2012.42%
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 286.50M | 292.73M | 303.91M | 324.01M | 329.54M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 286.50M | 292.73M | 303.91M | 324.01M | 329.54M |
| Cost of Revenue | 135.49M | 141.36M | 149.22M | 164.37M | 162.35M |
| Gross Profit | 151.01M | 151.36M | 154.70M | 159.64M | 167.19M |
| SG&A Expenses | 143.86M | 142.58M | 144.18M | 145.67M | 143.93M |
| Depreciation & Amortization | 10.99M | 11.99M | 13.05M | 14.88M | 16.33M |
| Other Operating Expenses | 5.76M | 5.76M | 5.76M | -- | -- |
| Total Operating Expenses | 323.44M | 331.31M | 343.52M | 357.38M | 353.74M |
| Operating Income | -36.94M | -38.59M | -39.60M | -33.37M | -24.20M |
| Income Before Tax | -237.39M | -239.16M | -191.64M | -199.36M | -9.29M |
| Income Tax Expenses | -12.67M | 3.87M | -7.29M | -7.00M | 4.83M |
| Earnings from Continuing Operations | -224.72 | -243.03 | -184.35 | -192.37 | -14.12 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -224.72M | -243.03M | -184.35M | -192.37M | -14.12M |
| EBIT | -36.94M | -38.59M | -39.60M | -33.37M | -24.20M |
| EBITDA | -11.36M | -13.18M | -14.29M | -4.92M | 4.57M |
| EPS Basic | -5.58 | -6.04 | -4.57 | -4.78 | -0.35 |
| Normalized Basic EPS | -0.55 | -0.58 | -0.60 | -0.53 | -0.40 |
| EPS Diluted | -5.58 | -6.04 | -4.58 | -4.78 | -0.35 |
| Normalized Diluted EPS | -0.55 | -0.58 | -0.60 | -0.53 | -0.40 |
| Average Basic Shares Outstanding | 162.24M | 161.53M | 160.72M | 159.90M | 159.18M |
| Average Diluted Shares Outstanding | 162.24M | 161.53M | 160.85M | 160.03M | 159.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
